CompletedNot Applicable

A Patient-Centered Communication Tool (UR-GOAL) Versus Usual Care for Older Patients With Acute Myeloid Leukemia, Their Caregivers, and Their Oncologists

United States161 participantsStarted 2022-06-17

Plain-language summary

The objective of this study is to evaluate the preliminary efficacy of the UR-GOAL tool in improving shared decision making and communication between older patients with AML and their oncologists in a pilot randomized trial.

Who can participate

Age range60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age ≥60 years
✓. Newly diagnosed AML or being worked up for possible AML
✓. Able to provide informed consent
✓. Agreement of their oncologist to participate in the study
✓. English-speaking
✓. Selected by the patient when asked if there is a "family member, partner, friend or caregiver \[age 21 or older\] with whom the patient discuss or who can be helpful in health-related matters;" patients who cannot identify such a person ("caregiver") can be eligible for the study. A caregiver need not be someone who lives with the patient or provides direct hands-on care. A caregiver can be any person who provides support (in any way) to the patient
✓. Able to provide informed consent
✓. English-speaking

What they're measuring

Shared Decision Making

Timeframe: Within 1-4 weeks after treatment initiation

Trial details

NCT IDNCT05335369

SponsorUniversity of Rochester

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-04-07

Results submitted2026-04-06

View on ClinicalTrials.gov More Acute Myeloid Leukemia trials